Clinical characteristics of patients with COVID-19
| Variable | Patients (n=12) |
| Age (years) | 54 (36, 76) |
| Male | 9 (75%) |
| Median BMI (range) | 27 (22, 45) |
| Comorbidities | |
| Cardiac | 6 (50%) |
| DM | 5 (42%) |
| Asthma/COPD | 2 (17%) |
| CKD | 4 (33%) |
| Stroke | 0 (0%) |
| Extubation trial | 5 (42%) |
| Time to tracheostomy* (days) | 17 (10, 27) |
| COVID-19 status prior to tracheostomy | |
| Positive | 9 (75%) |
| Negative | 1 (8%) |
| Unknown | 2 (17%) |
| Intraprocedural complication | 0 (0%) |
| Postprocedure bleeding | 2 (17%) |
| Tracheostomy decannulated | 5 (42%) |
| Discharged from hospital | 8 (67%) |
| Death | 4 (33%) |
| Follow-up (weeks) | 5 (3, 16) |
| Healthcare worker infection | 0 (0%) |
Data portrayed as either median (range) or n (%). Follow-up indicates number of weeks of follow-up since tracheostomy.
*Indicates time from initial intubation to tracheostomy placement.
BMI, body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus.